...
机译:用于增强的抗癌活性和降低肾毒性的双靶向双动铂(IV)平台
Natl Univ Singapore Dept Pharm 3 Sci Dr 2 Singapore 117543 Singapore;
Natl Univ Singapore Dept Pharm 3 Sci Dr 2 Singapore 117543 Singapore;
Nanyang Technol Univ Sch Mat Sci &
Engn 50 Nanyang Ave Singapore 639798 Singapore;
Natl Univ Singapore Canc Sci Inst Singapore 14 Med Dr Singapore 117599 Singapore;
Natl Univ Singapore Canc Sci Inst Singapore 14 Med Dr Singapore 117599 Singapore;
Natl Univ Singapore Canc Sci Inst Singapore 14 Med Dr Singapore 117599 Singapore;
Natl Univ Singapore Dept Chem 3 Sci Dr 2 Singapore 117543 Singapore;
Hebrew Univ Jerusalem Sch Pharm Inst Drug Res IL-91120 Jerusalem Israel;
Natl Univ Singapore Dept Pharm 3 Sci Dr 2 Singapore 117543 Singapore;
antitumor agents; drug discovery; platinum; prodrugs; sensitizers;
机译:用于增强的抗癌活性和降低肾毒性的双靶向双动铂(IV)平台
机译:使用双靶向策略提高铂(IV)前药的抗癌活性用二氯乙酸二氯乙酸轴配体
机译:使用双靶向策略提高铂(IV)前药的抗癌活性用二氯乙酸二氯乙酸轴配体
机译:通过ICP-MS和La-ICP-MS对新型铂(IV)基抗癌剂的药理行为研究
机译:二氯(4,4'-双(4,4,4-三氟丁基)-2,2'-联吡啶1铂,一种新型的顺铂类似物,在上消化道癌的临床前模型中表现出增强的抗癌活性。
机译:口服抗癌铂(IV)配合物氧铂和代谢物顺式-二氨基-四氯化铂-(IV)对NCI-H526细胞整体基因表达影响的比较
机译:使用双靶向策略提高铂(IV)前药的抗癌活性用二氯乙酸二氯乙酸轴配体